The Iodinated Contrast Crisis of 2022: A Near Miss or a Missed Opportunity?
AJNR. American journal of neuroradiology（2023）
摘要
The unprecedented global shortage of iodinated contrast media (ICM), commencing in late April 2022, was a direct result of excessive global reliance on one manufacturer, GE Healthcare, which produced much of its most widely used ICM, iohexol (Omnipaque), at a facility in Shanghai, China.[1][1],[2][2
更多查看译文
关键词
iodinated contrast crisis,missed opportunity
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要